Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Malaria to Infectious Disease Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Malaria to Infectious Disease Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Malaria Therapeutics Clinical Trials 28 Prominent Drugs 30 Clinical Trial Profile Snapshots 31 Appendix 532 Abbreviations 532 Definitions 532 Research Methodology 533 Secondary Research 533 About GlobalData 534 Contact Us 534 Disclaimer 534 Source 535

List of Tables Malaria Therapeutics, Global, Clinical Trials by Region, 2016* 6 Malaria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Malaria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Malaria Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Malaria Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Malaria Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Malaria to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15 Malaria Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Malaria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Malaria to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18 Malaria Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Malaria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Malaria Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Malaria Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Malaria Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Malaria Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Malaria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Malaria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 List of Figures Malaria Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Malaria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Malaria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Malaria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Malaria Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Malaria Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Malaria to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15 Malaria Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Malaria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Malaria to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18 Malaria Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Malaria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Malaria Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Malaria Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Malaria Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Malaria Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Malaria Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Malaria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 533

GlaxoSmithKline Plc Sanaria Inc. Sanofi Medical Research Council Unit, The Gambia Pfizer Inc. Novartis AG Sun Pharmaceutical Industries Limited Shin Poong Pharm.Co., Ltd. Medecins Sans Frontieres Q-Pharm Pty Limited